Somite Raises $5.3M in Pre-Seed Funding
Summary
Somite, a Boston, MA-based developer of AI for stem cell biology, raised $5.3M in Pre-Seed funding. The company intends to use the funs to continue development of its proprietary AlphaStem AI platform. Led by CEO Micha Breakstone, Somite.ai is developing AI foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies. Drawing from data-rich sources such as scRNA-Seq, scATAC-seq, and gene expression databases, the digital twin empowers Artificial Intelligence to swiftly uncover innovative protocols, identify regulators of cell differentiation, and conduct rapid optimization cycles. • Jonathan Rosenfeld, PhD: CTO and Co-founder – Head of the Fundamental AI group at MIT FutureTech • Olivier Pourquie, PhD: Professor of Genetics and Pathology, Harvard Medical School and Brigham and Women’s Hospital • Cliff Tabin, PhD: Chair of the Department of Genetics at Harvard Medical School